Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Global Epidemiology of Lung Cancer. Ann Glob
2019 · External reference
Unresolved reference
2021 · External reference
10.1038/s41588-019-0569-6
10.1038/s41588-019-0569-6 · External reference
Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis
10.3390/cancers12123709 · 2020 · External reference
10.1146/annurev.pathol.4.110807.092222
10.1146/annurev.pathol.4.110807.092222 · External reference
MiRNA-based Therapeutics for Lung Cancer
10.2174/1381612823666170714151715 · 2018 · External reference
10.1038/nrd.2016.246
10.1038/nrd.2016.246 · External reference
10.1016/j.jare.2020.08.012
10.1016/j.jare.2020.08.012 · External reference
10.3389/fgene.2019.00478
10.3389/fgene.2019.00478 · External reference
10.1038/ng.3564
10.1038/ng.3564 · External reference
Classification of the four main types of lung cancer using a microRNA-based diagnostic assay
10.1016/j.jmoldx.2012.03.004 · 2012 · External reference
The Roles of MicroRNA in Lung Cancer
2019 · External reference
10.1093/nar/gkt1025
10.1093/nar/gkt1025 · External reference
10.1093/nar/gkv1314
10.1093/nar/gkv1314 · External reference
DriverDBv3: a multi-omics database for cancer driver gene research
2019 · External reference
10.1093/nar/gks1238
10.1093/nar/gks1238 · External reference
YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research
10.1093/nar/gku1156 · 2015 · External reference
YM500v3: a database for small RNA sequencing in human cancer research
10.1093/nar/gkw1084 · 2017 · External reference
10.1093/nar/gkt1181
10.1093/nar/gkt1181 · External reference
10.1093/nar/gkv1188
10.1093/nar/gkv1188 · External reference
10.1186/gb-2010-11-10-r106
10.1186/gb-2010-11-10-r106 · External reference
Package ‘survival’
2015 · External reference
10.1038/oncsis.2015.40
10.1038/oncsis.2015.40 · External reference
GSOAP: A tool for visualisation of gene set over-representation analysis
2020 · External reference
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway
10.1158/0008-5472.can-13-2995 · 2014 · External reference
Data Normalization Strategies for MicroRNA Quantification
10.1373/clinchem.2015.239459 · 2015 · External reference
10.1093/carcin/bgt285
10.1093/carcin/bgt285 · External reference
10.1128/mcb.00175-08
10.1128/mcb.00175-08 · External reference
MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2
10.1091/mbc.e09-05-0386 · 2009 · External reference
Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression
10.1093/carcin/bgs165 · 2012 · External reference
Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer
10.1038/s41598-020-73659-z · 2020 · External reference
Cancer-associated miRNAs and their therapeutic potential
2021 · External reference
10.1016/j.mam.2018.07.003
10.1016/j.mam.2018.07.003 · External reference
Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer
10.1186/s12931-014-0149-3 · 2014 · External reference
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma
10.1016/j.omtn.2021.04.020 · 2021 · External reference
MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN)
10.1186/2045-3701-4-62 · 2014 · External reference
10.1038/nature04303
10.1038/nature04303 · External reference
10.1016/j.omtn.2020.07.021
10.1016/j.omtn.2020.07.021 · External reference
MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2
10.1016/j.biopha.2017.11.105 · 2017 · External reference
miR-31 displays subtype specificity in lung cancer
10.1158/0008-5472.can-20-2769 · 2021 · External reference
10.1038/s41467-017-01059-5
10.1038/s41467-017-01059-5 · External reference
Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for nonsmall cell lung cancer
2020 · External reference
Aberrant miR-1246 expression promotes radioresistance in non-small cell lung cancer: a potential prognostic biomarker and radiotherapy sensitization target
2020 · External reference
Early diagnostic and prognostic value of serum exosomal miR-1246 in non-small cell lung cancer
2020 · External reference
miRNA Expression Profile in the N2 Phenotype Neutrophils of Colorectal Cancer and Screen of Putative Key miRNAs
10.2147/cmar.s251427 · 2020 · External reference
Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
10.18632/oncotarget.24942 · 2018 · External reference
10.1016/j.stemcr.2016.05.012
10.1016/j.stemcr.2016.05.012 · External reference
10.1016/j.bbrc.2018.12.114
10.1016/j.bbrc.2018.12.114 · External reference
Selenium-binding protein 1 alters energy metabolism in prostate cancer cells
10.1002/pros.24028 · 2020 · External reference
Unresolved reference
2007 · External reference
10.1038/sj.onc.1206134
10.1038/sj.onc.1206134 · External reference
SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties
10.3389/fimmu.2020.622598 · 2020 · External reference
JAML promotes CD8 and gammadelta T cell antitumor immunity and is a novel target for cancer immunotherapy
10.1084/jem.20202644 · 2021 · External reference
Expression Depression of CD300LG-gamma in Human Pulmonary Carcinoma
10.1089/mab.2015.0043 · 2016 · External reference
Novel natural killer cell-mediated cancer immunotherapeutic activity of anisomycin against hepatocellular carcinoma cells
10.1038/s41598-018-29048-8 · 2018 · External reference
A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma
10.1038/s41598-019-48243-9 · 2019 · External reference
10.1016/j.cell.2020.05.043
10.1016/j.cell.2020.05.043 · External reference
10.2217/fon-2018-0164
10.2217/fon-2018-0164 · External reference
10.1158/1541-7786.mcr-18-0392
10.1158/1541-7786.mcr-18-0392 · External reference
10.1016/j.ygeno.2022.110279
10.1016/j.ygeno.2022.110279 · External reference
10.1038/mt.2012.95
10.1038/mt.2012.95 · External reference
Evaluation of locked nucleic acid–modified small interfering RNA in vitro and in vivo
10.1158/1535-7163.mct-06-0195 · 2007 · External reference
10.1038/s41578-021-00358-0
10.1038/s41578-021-00358-0 · External reference
Advances and Challenges of Liposome Assisted Drug Delivery
10.3389/fphar.2015.00286 · 2015 · External reference
Theranostics for cancer therapy
10.2174/1567201811310030013 · 2013 · External reference
